Back
Aprea Therapeutics Stock Price Chart
AI DIVIDENDS: No. 1 Way to Collect Passive Income
Click here to get it for free.
Sell
4
APRE
Aprea Therapeutics
Last Price:
4.05
Seasonality Move:
-10.67%
7 Day Trial
ALL ACCESS PASS
$
7
Follow Warren Buffett's big oil bet with this ETF
Discover all about it HERE.- The current trend is moderately bullish and APRE is experiencing slight selling pressure.
Aprea Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.06 | Sell |
| 20-day SMA: | 3.42 | Buy |
| 50-day SMA: | 3.29 | Buy |
| 200-day SMA: | 4.74 | Sell |
| 8-day EMA: | 3.97 | Sell |
| 20-day EMA: | 3.65 | Buy |
| 50-day EMA: | 3.47 | Buy |
| 200-day EMA: | 4.34 | Sell |
Aprea Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.3 | Buy |
| Relative Strength Index (14 RSI): | 57.66 | Buy |
| Chaikin Money Flow: | -6773 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.57 - 4.01) | Buy |
| Bollinger Bands (100): | (3.05 - 4.11) | Buy |
Aprea Therapeutics Technical Analysis
| Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Aprea Therapeutics Stock
Is Aprea Therapeutics Stock a Buy?
- Aprea Therapeutics share price is 3.91 while APRE 8-day simple moving average is 4.06, which is a Sell signal.
- The stock price of APRE is 3.91 while Aprea Therapeutics 20-day SMA is 3.42, which makes it a Buy.
- Aprea Therapeutics 50-day simple moving average is 3.29 while APRE share price is 3.91, making it a Buy technically.
- APRE stock price is 3.91 and Aprea Therapeutics 200-day simple moving average is 4.74, creating a Sell signal.
APRE Technical Analysis vs Fundamental Analysis
Sell
4
Aprea Therapeutics (APRE)
is a Sell
Is Aprea Therapeutics a Buy or a Sell?
-
Aprea Therapeutics stock is rated a Sell
The current Aprea Therapeutics [APRE] share price is $3.91. The Score for APRE is 4, which is 92% below its historic median score of 50, and infers higher risk than normal.
Aprea Therapeutics Stock Info
Market Cap:
21.24M
Price in USD:
3.91
Share Volume:
13.94K
Aprea Therapeutics 52-Week Range
52-Week High:
8.85
52-Week Low:
2.15
Sell
4
Aprea Therapeutics (APRE)
is a Sell
Aprea Therapeutics Share Price Forecast
-
What is the Aprea Therapeutics stock price today?
The Aprea Therapeutics stock price is 3.91 USD today. -
Will APRE stock go up or go down?
Aprea Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Aprea Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Aprea Therapeutics is overvalued.
Is Aprea Therapeutics Stock a Buy?
- Aprea Therapeutics share price is 3.91 while APRE 8-day exponential moving average is 3.97, which is a Sell signal.
- The stock price of APRE is 3.91 while Aprea Therapeutics 20-day EMA is 3.65, which makes it a Buy.
- Aprea Therapeutics 50-day exponential moving average is 3.47 while APRE share price is 3.91, making it a Buy technically.
- APRE stock price is 3.91 and Aprea Therapeutics 200-day simple moving average is 4.34, creating a Sell signal.
Fundamental Analysis of Aprea Therapeutics
Is Aprea Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.57 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.54 per share, and an increase next year of $1.77 per share.
Technical Analysis of Aprea Therapeutics
Should I short Aprea Therapeutics stock?
- APRE Moving Average Covergence Divergence (MACD) indicator is 0.3, suggesting Aprea Therapeutics is a Buy
- Aprea Therapeutics Relative Strength Index (RSI) is 57.66, which suggest Aprea Therapeutics is overbought
- The Bollinger Bands (25) for Aprea Therapeutics is (2.57 - 4.01), which suggest Aprea Therapeutics is a Buy
- The Bollinger Bands (100) for Aprea Therapeutics is (3.05 - 4.11), which suggest Aprea Therapeutics is a Buy
* Aprea Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.